About the Program and Guideline Development

The Clinical Guidelines Program is a collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute, Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. 

History: The NYSDOH AI Guidelines Program began in the late 1980s in response to the clinical management challenges of the HIV/AIDS epidemic in New York, and has continuously provided clinical guidance for HIV care providers in New York State. As the AIDS Institute has expanded its mission over time, so has this program, which now publishes evidence-based, timely clinical practice guidelines for HIV care and prevention, and for treatment of viral hepatitis, other sexually transmitted infections, and substance use disorders. Like the AIDS Institute, the clinical guidelines program also addresses healthcare and prevention for  the LGBTQ community. 

Mission: To produce and disseminate evidence-based, state-of-the-art clinical practice guidelines that establish  uniform standards of care for practitioners who provide prevention or treatment of HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders for adults throughout New York State in the wide array of settings in which those services are delivered. 

Goals: As part of the AI Quality of Care Programs, the goal of the Clinical Guidelines Program is to support care providers in improving the health and well being of adults in New York State who have or are at risk of acquiring HIV, viral hepatitis, other sexually transmitted infections, and substance use orders. The Guidelines Program also supports the New York State Ending the Epidemic Initiative, including the HIV treatment-as-prevention (TasP) strategy, with strong recommendations for increased testing and linkage to care, immediate initiation of antiretroviral therapy, increased awareness of acute HIV infection, and dedicated efforts to maintain HIV viral load suppression.

Expert committees: The AIDS Institute Medical Director invites and appoints committees of clinical and public health experts from throughout NYS to ensure that the guidelines are practical, immediately applicable, and meet the needs of care providers and stakeholders in all major regions of NYS, all relevant clinical practice settings, key NYS agencies, and community service organizations.

Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.

Audience: AI clinical care guidelines are produced and disseminated to clinicians in New York State who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs, and substance use disorders. Guideline recommendations are based on published evidence and the collective expertise of committee members and are practical for use by specialists and low-volume care providers. All involved are committed to publishing guidelines that are used in the real world by busy care providers, who find them to be useful and readily accessible tools with immediate application in daily practice.

The AI has always sought to publish guidelines that inform primary care providers who do not specialize in HIV but who do provide care for people with HIV within New York State. The guidelines are grounded in current research, supported by evidence, and reflect the breadth of experience of committee members who specialize in HIV, HCV, STIs, and substance use and who know the realities of providing clinical care throughout New York State and in a broad array of clinical settings.

Dissemination and implementation: All clinical care guidelines are freely accessible and are published at www.hivguidelines.org. The AI disseminates the guidelines through multiple channels and numerous programs, and the Clinical Education Initiative provides training for care providers in New York State in support of guideline implementation.  

JHU Clinical Guidelines Program: The JHU School of Medicine, Division of Infectious Diseases, has collaborated with the NYSDOH AI since 1999 to develop and disseminate the AI clinical guidelines and related quality-of-care information. The Clinical Guidelines program website is managed by the JHU program.

Funding: The Clinical Guidelines Program is supported by New York State funds allocated through a grant to the JHU School of Medicine to support all activities of the program.

Program Leadership and Staff

New York State Department of Health AIDS Institute

The Office of the Medical Director oversees the program.

• Charles J. Gonzalez, MD, Medical Director
• Lyn Stevens, MS, NP, ACRN, Clinical Advisor to the AIDS Institute
• Laura Duggan Russell, MPH, AI Guidelines Program Director

The AIDS Institute OMD consists of public health professionals dedicated to enhancing the quality of life for persons with HIV by improving prevention and health care services through performance measurement and science-based initiatives. The Office of the Medical Director oversees numerous programs and initiatives including:

• Clinical Guidelines Program
• Quality of Care Program
• Clinical Education Initiative
• Education and Training Initiative
• Materials Initiative

Johns Hopkins University School of Medicine Clinical Guidelines Program

The Johns Hopkins University School of Medicine, Division of Infectious Diseases, has collaborated with the NYSDOH AIDS Institute since 1999 to develop and disseminate HIV clinical guidelines and related quality-of-care information.

 Christopher J. Hoffmann, MD, MPH, Director, JHU-NYSDOH AI Guidelines Program,  provides leadership and strategy to the program and lends extensive experience in both HIV clinical care and guidelines development, as well as a resolute commitment to training for HIV care providers.

The JHU team manages all aspects of guidelines development and dissemination and program administration through the efforts of the following program staff:

• Mary Beth Hansen, MA, Program Director
• Jennifer R Ham, MPH, Senior Medical Editor
• Johanna L Gribble, MA, Senior Medical Editor
• Rachel Lastra, Senior Medical Editor
• Jesse M Ciekot, Program Administrator

Contact Information

JHU: This website is managed and maintained by the staff of the JHU Clinical Guidelines Program. If you have questions about the website or about the JHU Clinical Guidelines program, please send an email to aiguidelines@jhmi.edu.

Mailing address: JHU Clinical Guidelines Program, 1550 Orleans Street, CRB II, Office 1M11, Baltimore, MD 21287-0014

NYSDOH AIDS Institute: If you have questions about the NYSDOH AIDS Institute Clinical Guidelines Program, please contact Laura Russell, Program Director: laura.russell@health.ny.gov.

Mailing address: New York State Department of Health AIDS Institute, Office of the Medical Director, 90 Church Street, 13th Floor, New York, New York 10007-2919

Remembering Dr. John G. Bartlett

Christopher J. Hoffmann, MD, MPH; January 25, 2021

Dr. John G. Bartlett (fondly referred to as “JB”), a giant in the worlds of medicine, infectious diseases, and HIV, passed away on January 19, 2021. JB discovered, innovated, and taught at every opportunity. He shared his love of medicine and his compassion in many ways, and HIV care was just one of JB’s innumerable and remarkable contributions.

JB’s work in HIV started soon after he came to Johns Hopkins Hospital in 1980 as chief of the Division of Infectious Diseases. Once the HIV epidemic took hold, it ravaged the urban neighborhoods around Johns Hopkins, as it did in so many other metropolitan areas. In response, JB wanted to offer outpatient care for the generally poor, Black, and uninsured people contracting this new, fatal, and highly stigmatized disease, so he surreptitiously started a clinic in an unused space in the basement of Johns Hopkins Hospital. A year later, as JB recalled, the Department of Medicine Chairman asked whether he had heard of AIDS and suggested that Hopkins do something about it. JB then revealed his secret clinic and built support from the administration for both the clinic and an inpatient HIV service.

At the time, those caring for people with HIV shared the limited knowledge of what could work to palliate this disease however they could—at conferences and through journal publications. In the face of a devastating disease with quickly evolving knowledge, peer-reviewed publication moved way too slowly for JB, who sought ways to update clinicians around the world as quickly as possible. In 1994, he began writing his book Medical Management of HIV Infection, which he updated annually for close to 20 years. He started a local newsletter for the National Institutes of Health AIDS Clinical Trial Group that grew into the international Hopkins HIV Report, and under his leadership, the Johns Hopkins AIDS Service website was launched to deliver rich, up-to-date content globally in 1997. In 1996, JB and Dr. Anthony Fauci began their work as co-chairs of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents to develop and disseminate national treatment guidance.

In 1999, JB was granted the contract for developing and disseminating the guidelines of the New York State Department of Health AIDS Institute clinical guidelines program, which was launched in the mid-1980s as the first HIV guidelines program in the world. JB brought his prestige, insight, and collegiality to this fledgling operation and helped shape it into a respected and trusted source of practical and effective HIV clinical guidance. In 2014, the AIDS Institute presented the Linda Laubenstein Award to the guidelines program to recognize its development of clinical guidelines that address the care and treatment of people with HIV in New York State and provide a framework for excellence in the clinical care of people living with HIV. This program, which has grown and thrived for more than 20 years in the Johns Hopkins University Division of Infectious Diseases, was just one of the innumerable initiatives and projects that JB wholeheartedly embraced.

To all of his work, JB brought an encyclopedic and up-to-the-minute knowledge of medicine, joy in sharing his knowledge, seemingly boundless energy (he was famous for starting his workday at 3 AM), and a nurturing spirit that all around him appreciated.

I sought to and completed my medicine and infectious diseases training at Johns Hopkins University because of the stellar program built by JB and specifically because of his eminence in the world of HIV. I had the privilege of providing care on the HIV service when JB was attending, first in 2003, and always treasured his immense knowledge and infectious joie de vivre. I sought his guidance throughout the time I worked with him at Johns Hopkins and even after he retired. In 2014, when JB asked me to carry on the work he started with the AIDS Institute’s HIV clinical guidelines program, I felt honored and remain glad to lead this important project at Hopkins and make contributions that extend Dr. John Bartlett’s legacy of ensuring that people with HIV receive informed and compassionate care.

Remembering Humberto Cruz

April 25, 2019

It is with great sadness that we share that our colleague, leader and friend, Humberto Cruz, has passed away.  This is indeed a tremendous loss for so many of us. Humberto will be greatly missed.

The AIDS Institute would like to take this time to remember Humberto’s contributions to improving health outcomes for persons living with HIV.  For more than 30 years, he served in management positions in New York State government and community-based organizations–with 23 of those spent serving with the AIDS Institute and more than five years as Director.   He was pivotal in the development of virtually every major HIV/AIDS policy and program in New York State for more than 20 years and instrumental in the development of a comprehensive continuum of care for people with HIV and AIDS.  Among his major accomplishments was the development of enhanced Medicaid rates for HIV care, the implementation of client-centered programs that reimburse providers for the delivery of care to the uninsured, the development of managed care for persons with HIV, the initiation of programs that facilitate the participation of persons living with HIV/AIDS in program planning, and the development of initiatives to address the aging of the epidemic. He was also instrumental in expanding the role of the AIDS Institute to be inclusive of Hepatitis C, STDs, and Epidemiology.

His involvement in HIV/AIDS policy has extended well beyond New York State. As an executive committee member and one of the founders of the National Alliance of State and Territorial AIDS Directors (NASTAD), he deliberated HIV/AIDS policy at the national level. In 2010, Humberto appointed to serve on the Presidential Advisory Council on HIV/AIDS (PACHA), providing recommendations on national and global issues and contributing to the National HIV/AIDS Strategy.

Through his work, he earned the respect and admiration of staff and many community partners. He had a keen ability to reach out to people with respect and understanding and to embrace multiple perspectives. He was truly an exceptional leader, powerful teacher, and valued mentor.

Further information will be shared once it is available.

Peace to all.

Johanne E. Morne, MS

Director, AIDS Institute

Guideline Development and Committees

Expert Committees

Composition: The Clinical Guidelines Program works directly with committees composed of experts in the field who represent multiple disciplines (medicine, nursing, psychology, pharmacy, public health, social work, mental health), clinical specialties (infectious diseases, family medicine, obstetrics and gynecology, hepatology, pediatrics, psychiatry, dentistry, prevention, etc.), and various geographic regions of New York State.

A Clinical Guidelines Program Steering Committee provides oversight and strategy to the following Clinical Guidelines Program committees, each of which is responsible for developing and updating clinical practice guidelines that fall under its area of expertise. Current committees (February 2020) include the following:

• Medical Care Criteria Committee (Adult HIV and related guidelines)
• Hepatitis C Virus Infection Guidelines Committee
• Perinatal Transmission Prevention Guideline Committee
• Substance Use Guidelines Committee

Financial disclosure and confidentiality agreement: All potential and active committee members are required to sign a confidentiality agreement and to disclose annually all financial relationships with commercial entities or gifts that may be actual, potential, or perceived as conflicts of interest. Committee members must report financial relationships with commercial entities that have existed in the 12 months prior to or are expected to exist in the 12 months after the date on which they sign their disclosure form.

Guideline development process: When the Clinical Guidelines Program identifies the need to develop or update a guideline, the committee under whose purview the guideline falls convenes to determine the goals of the guideline and its content, review the published literature, and weigh new evidence for recommendations. Text is then drafted by an author who has experience with the topic of the guideline. The guideline draft is edited by the team at JHU, and then reviewed and modified by the committee. This rigorous development process may entail multiple rounds of review, revision, rating, and editing. Decision-making occurs by consensus, and all guideline recommendations are reviewed by and receive the consensus approval of the full guideline committee. 

Evidence-based Recommendations: All recommendations are rated to reflect the strength of each recommendation and the quality of the supporting evidence. Ratings are reached through review of the evidence and consensus decision. If the published evidence in support of a particular recommendation is not sufficient, the group relies on collective best practices experience to develop a final statement. The rating scheme for recommendations appears below.

External review: All guidelines are reviewed by external experts in the field and by the AIDS Institute’s Consumer Advisory Committee. 

Final approval: The guideline is submitted to the AIDS Institute for review and final approval prior to publication. The AI may request additional review by other agencies and organizations when applicable.

Guideline Updates: Members of guideline committees monitor developments ongoing to maintain guideline currency, at regular intervals. Newly published data that provides support for existing recommendations will be cited in the text and the studies will be added to the reference list. If newly published data prompts a revision to recommendations or rationale, a planning committee proposes appropriate edits and determines whether any changes warrant full committee review and approval. 

Medical Care Criteria Committee (MCCC; Adult HIV Treatment and Prevention)

Updated  June 2022 | Recent changes to the MCCC

Guidelines Writing Group

Chair:  Steven M. Fine, MD, PhD
University of Rochester Medical Center, Rochester, NY
No disclosures

Vice-Chair:  Rona M. Vail, MD
Callen-Lorde Community Health Center, New York, NY
No disclosures

Chair Emeritus: Joseph P. McGowan, MD, FACP, FIDSA
North Shore University Hospital, Manhasset, NY
Institutional grant support: Gilead

Chair Emeritus: Samuel T. Merrick, MD
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY
No disclosures

Transgender Health Specialist: Asa E. Radix, MD, MPH, PhD, FACP, AAHIVS
Callen-Lorde Community Health Center, New York, NY
No disclosures

Community Advisor:  Jessica Rodrigues
Senior HIV/Family Planning Advisor,  USAID Office of HIV/AIDS
New York, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health, AIDS Institute, New York, NY
No disclosures

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

Contributing Members

Elizabeth A. Asiago-Reddy, MD, MS
SUNY Upstate Medical University, Syracuse, NY
No disclosures

Jessica M. Atrio, MD, MSc
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

James C. M. Brust, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Michelle S. Cespedes, MD, MS
Icahn School of Medicine at Mount Sinai, New York, NY
Scientific Advisor: Gilead, ViiV

Guillermo Chacón
Latino Commission on AIDS; Hispanic Health Network
No disclosures

Ethan A. Cowan, MD, MS
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Mary E. Dyer, MD
Sun River Health, Poughkeepsie, NY
No disclosures

John J. Faragon, PHARMD, BCPS, AAHIVP
Albany Medical Center, Albany, New York
Scientific Advisor: ViiV

Shauna H. Gunaratne, MD, MPH
Columbia University Medical Center, New York, NY
No disclosures

Bruce E. Hirsch, MD, FACP, FIDSA, AAHIVS
North Shore University Hospital, Manhasset, NY
No disclosures

Christine A. Kerr, MD
Galileo Health
No disclosures

Jeremy D. Kidd, MD, MPH
New York-Presbyterian Hospital, Columbia University, New York, NY
No disclosures

Hector I. Ojeda-Martinez, MD
Nuvance Health/Health Quest Medical Practice, Poughkeepsie, NY
No disclosures 

Meera Shah, MD, MPH, MS, AAHIVS
Planned Parenthood Hudson Peconic, Elmsford, NY
No disclosures

Sanjiv S. Shah, MD, MPH, AAHIVM, AAHIVS
NYC Health + Hospitals/Gotham Health, Gouverneur, New York, NY
No disclosures

Eugenia L. Siegler, MD
Weill Cornell Medical College, New York, NY
No disclosures

Maria Teresa (Tess) Timoney, MS, RN, CNM
Bronx Prevention Center, ICAP at Columbia, Bronx, NY
No disclosures

Benjamin W. Tsoi, MD, MPH
Bureau of HIV/AIDS Prevention and Control
New York City Department of Health and Mental Hygiene, New York, NY
No disclosures

Marguerite A. Urban, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY
No disclosures

Antonio E. Urbina, MD 
The Mount Sinai Hospital, Comprehensive Health Program-Downtown, New York, NY
Scientific Advisor: Gilead, Janssen, Merck, ViiV

Geoffrey A. Weinberg, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY
No disclosures

Changes to MCCC Membership

June 2022

• Joined as a contributing members: 
  • Elizabeth A. Asiago-Reddy, MD, MS, SUNY Upstate Medical University, Syracuse, NY
  • Michelle S. Cespedes, MD, MS, Icahn School of Medicine at Mount Sinai, New York, NY

April 2022

• Appointed Chair:  Steven M. Fine, MD, PhD, University of Rochester Medical Center, Rochester, NY
• Appointed Chair Emeritus: Joseph P. McGowan, MD, FACP, FIDSA, North Shore University Hospital, Manhasset, NY

January 2022

• Joined as a contributing member: Meera Shah, MD, MPH, MS, AAHIVS, Planned Parenthood Hudson Peconic
• Stepped down: Oni J. Blackstock, MD, MHS, Health Justice

August 2021

• Joined as a contributing member:  Guillermo Chacón, Latino Commission on AIDS; Hispanic Health Network
• Stepped down:
  • Elliot DeHaan, MD,  New York-Presbyterian Hospital/Weill Cornell Medical Center
  • Noga Shalev, MD, Columbia University Medical Center

July 2021

• Joined as a writing group member: Jessica Rodrigues, AVAC

March 2021

• Joined as contributing members:
  • John J. Faragon, PHARMD, BCPS, AAHIVP, Albany Medical Center
  • Shauna H. Gunaratne, MD, MPH, Columbia University Medical Center
  • Bruce E. Hirsch, MD, FACP, FIDSA, AAHIVS, North Shore University Hospital
• Stepped down: 
  • John M. Conry, PharmD, AAHIVP, FNAP, St. John’s University
  • Annette Gaudino, Treatment Action Group (TAG)
  • Jeremiah Johnson, Treatment Action Group (TAG)
  • Eugene D. Morse, PharmD, FCCP, BCPS, University at Buffalo School of Pharmacy & Pharmaceutical Sciences

February 2021

• Joined as a contributing member: Benjamin W. Tsoi, MD, MPH,  Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene

July 2020

• Joined as a contributing member: Ethan A. Cowan, MD, MS, Icahn School of Medicine at Mount Sinai
• Stepped down: Daniel J. Egan, MD, Columbia University Vagelos College of Physicians and Surgeons

January 2020

• Joined as contributing members:
  •  Jessica M. Atrio, MD, MSc, Albert Einstein College of Medicine/Montefiore Medical Center
  • Oni J. Blackstock, MD, MHS, New York City Department of Health and Mental Hygiene
• Stepped down: Julie E. Myers, MD, MPH, New York City Department of Health and Mental Hygiene

December 2019

• Stepped down:
  • Jack Fuhrer, MD, Stony Brook University School of Medicine
  • Luz Amarilis Lugo, MD, Mount Sinai Comprehensive Health Program-Downtown
  • Cynthia H. Miller, MD, Albany Medical Center
  • David C. Perlman, MD, Icahn School of Medicine at Mount Sinai

Hepatitis C Virus (HCV) Guideline Committee

Updated July 2021 | Recent changes to the HCV Guideline Committee

Guidelines Writing Group

Chair: Joshua S. Aron, MD
Elmhurst Hospital Center, Elmhurst, NY
No disclosures

Chair Emerita: Christine A. Kerr, MD
Galileo Health
No disclosures

Contributor: David E. Bernstein, MD, FAASLD, FACG, AGAF, FACP
Hofstra-Northwell School of Medicine, Manhasset, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

AIDS Institute Clinical Representative, Viral Hepatitis: Colleen Flanigan, RN, MS
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

Contributing Members 

Mary Angerame, MS, APN-BC
Jordan Health, Rochester, NY
No disclosures

Ayse Aytaman, MD, AGAF, FACG
Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY
No disclosures

Donald P. Kotler, MD
Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY
No disclosures

Kristen Marks, MD
Weill Cornell Medical College, New York, NY
No disclosures

Brianna L. Norton, DO, MPH
Montefiore Medical Group, Bronx, NY
No disclosures

Andrew H. Talal, MD, MPH
SUNY Buffalo , Buffalo, NY
Scientific Advisor:  Abbott, Merck; honorarium recipient: Gilead

Jeffrey J. Weiss, PhD, MS
Mount Sinai School of Medicine, New York, NY
No disclosures

Recent Changes to the HCV Guideline Committee

April 2021

• Joined as a contributing member: Andrew H. Talal, MD, MPH, SUNY Buffalo 

March 2021

• Joined as a contributing member: Donald P. Kotler, MD, Albert Einstein College of Medicine/Jacobi Medical Center
• Stepped down as a writing group member: Annette Gaudino, Treatment Action Group (TAG)

September 2020

• Stepped down as Vice-Chair: Ponni V. Perumalswami, MD, Icahn School of Medicine at Mount Sinai

February 2020

• Appointed Vice-Chair: Ponni V. Perumalswami, MD, Icahn School of Medicine at Mount Sinai
• Stepped down as Co-Chair; appointed Chair Emerita: Christine A. Kerr, MD, Galileo Health

Perinatal Transmission Prevention Guideline Committee

Updated March 2021

Leadership

Chair: Marc D. Foca, MD
Children’s Hospital at Montefiore Albert Einstein College of Medicine, Bronx, NY
No disclosures

Chair Emeritus: Rodney L. Wright, MD, MS
Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
No disclosures

Chair Emeritus: Murli U. Purswani, MBChB, FAAP
Bronx-Lebanon Hospital Center, Bronx, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

AIDS Institute Clinical Representative, Perinatal HIV Prevention: Suzanne Kaufman, MPH, BSN, AACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

Contributing Members

Helene Bernstein, MD, PhD
Upstate Medical University, Syracuse, NY
No disclosures

Aracelis D. Fernández, MD, FAAP
Harlem Hospital Center, New York, NY
No disclosures

Courtney Olson-Chen, MD
University of Rochester Medical School, Rochester, NY
No disclosures

Maria Teresa (Tess) Timoney, MS, RN, CNM
Bronx Prevention Center, ICAP at Columbia, Bronx, NY
No disclosures

Geoffrey A. Weinberg, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY
No disclosures

Recent Changes to the Perinatal Transmission Prevention Guideline Committee

March 2021

• Stepped down as a writing group member: Annette Gaudino, Treatment Action Group (TAG)

Substance Use Guidelines Committee

Updated October 2021 | Recent changes to the Substance Use Guidelines Committee

Leadership

Chair (10/26/21):  Susan D. Whitley, MD
New York City Health + Hospitals/Kings County, Brooklyn, NY
No disclosures

Vice-Chair (10/26/2021): Timothy J. Wiegand, MD
University of Rochester Medical Center, Rochester, NY
No disclosures

Medical Director: Charles J. Gonzalez, MD
New York State Department of Health AIDS Institute, New York, NY

Clinical Advisor to the AIDS Institute: Lyn C. Stevens, MS, NP, ACRN
New York State Department of Health AIDS Institute, Albany, NY
No disclosures

Director, JHU-NYSDOH AI Guidelines Program: Christopher J. Hoffmann, MD, MPH
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD
No disclosures

AIDS Institute Clinical Representative, Harm Reduction in Healthcare: Sharon L. Stancliff, MD
New York State Department of Health AIDS Institute, New York, NY
No disclosures

AIDS Institute Clinical Representative, Drug User Health: Narelle Ellendon, RN
New York State Department of Health AIDS Institute, New York, NY
No disclosures

Contributing Members

Angela G. Giovanniello, PharmD, AAHIVP
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Judith L. Griffin, MD
REACH Medical, Ithaca, NY
No disclosures

Julia K. Hunter, MD, MPH, FASAM
United Health Services Hospitals, Inc., Binghamton, NY
No disclosures

Giliane Joseph, MD
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Tiffany Y. Lu, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

Yonina Mar, MBBS, MSc
Mount Sinai Beth Israel, New York, NY
No disclosures

Shadi Nahvi, MD, MS
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
No disclosures

David C. Perlman, MD
Icahn School of Medicine at Mount Sinai, New York, NY
No disclosures

Sara Lorenz Taki, MD
Greenwich House MMTP, New York, NY
No disclosures

Recent Changes to the Substance Use Guidelines Committee

October 2021

• Appointed Chair: Susan D. Whitley, MD, New York City Health + Hospitals/Kings County
• Appointed Vice-Chair: Timothy J. Wiegand, MD, University of Rochester Medical Center

August 2021

• Joined as contributing members: 
  • Judith L. Griffin, MD, REACH Medical
  • Julia K. Hunter, MD, MPH, FASAM, United Health Services Hospitals, Inc.
  • Tiffany Y. Lu, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center
  • Yonina Mar, MBBS, MSc, Mount Sinai Beth Israel
  • Sara Lorenz Taki, MD, Greenwich House MMTP

June 2021

• Stepped down as a contributing member:  Hillary Kunins, MD, MPH, MS, New York City Department of Health and Mental Hygiene

April 2021

• Stepped down as Chair: Chinazo O. Cunningham, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center 

March 2021

• Stepped down as a writing group member: Annette Gaudino, Treatment Action Group (TAG)
• Stepped down as a contributing member: Raymond Harvey, MD, Institute for Family Health

July 2020

• Stepped down as contributing members: 
  • Marcus Bachhuber, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center
  • Michael L. Christie, MD, University of Rochester Medical Center
• Stepped down as Vice-Chair: Kelly S. Ramsey, MD, MPH, MA, FACP, New York State Office of Addiction Services and Support

Institutional, Agency, and Program Liaison Advisory Group

Updated June 2022

Sheldon T. Brown, MD
Infectious Diseases
Hudson Valley VA Healthcare System, Montrose, NY
No disclosures

Douglas Fish, MD
Office of Health Insurance Programs
New York State Department of Health, Albany, NY
No disclosures

Emma Kaplan-Lewis, MD
HIV Services, Office of Population Health
NYC Health and Hospitals, New York, NY
No disclosures

Ralph Liporace, MD
Coxsackie Correctional Facility
NYS Department of Corrections and Community Service, Albany NY
No disclosures

Monica Parker, PhD
Bloodborne Viruses Laboratory, Wadsworth Center
New York State Department of Health, Albany, NY
No disclosures

Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM
NYS Office of Addiction Services and Supports, Albany, NY 
No disclosures

Thomas Smith, MD
Office of Mental Health
New York State Psychiatric Institute, New York, NY
No disclosures

William M. Valenti, MD, FIDSA
Trillium Health, Rochester, NY
Medical Society of the State of New York
No disclosures

About This Website

Purpose

The NYSDOH AI Clinical Guidelines website publishes the clinical practice guidelines and related materials produced by the Clinical Guidelines Program. The program is a collaborative effort of the New York State Department (NYSDOH) of Health AIDS Institute’s (AI) Office of the Medical Director (OMD) and the Johns Hopkins University School of Medicine, Division of Infectious Diseases. This website is maintained and managed by the JHU Clinical Guidelines program, within the Johns Hopkins University School of Medicine, Division of Infectious Diseases. 

Production and Development 

• WordPress development and programming: Patrick Harris, Cyberian Frontier
• Graphic design: Laura Hatcher, Hatcher Design Office
• Managing Editor: Mary Beth Hansen
• Website production: Johanna Gribble and Jesse Ciekot

Editorial Policies & Procedures

This website is produced and maintained by the JHU Clinical Guidelines Program at the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. The site does not purport to advance any official positions of JHU, the JHU School of Medicine, or the Division of Infectious Diseases. The JHU Clinical Guidelines Program, in collaboration with the NYSDOH AI, maintains editorial control of all materials published on this site, and unless noted otherwise, all materials posted on this site have been produced under the auspices NYSDOH AIDS Institute Clinical Guidelines Program.

Mention of specific products by generic or brand name does not constitute an endorsement by the Clinical Guidelines Program, or its committee members, editors, or staff; NYSDOH or the AI or its staff. Any mention of specific products is for informational purposes only. Regarding specific products or drugs, physicians and other health care providers are advised to consult their normal resources before prescribing to their patients.

The JHU Clinical Guidelines Program does not provide clinical care and does not provide clinical or medical advice. 

Contact Us 

• Mailing address: JHU HIV Clinical Guidelines Program, 1550 Orleans Street, CRB II, Office 1M11, Baltimore, MD 21287-0014.
• E-mail for general comments or questions: aiguidelines@jhmi.edu 
• E-mail for content-specific comments, questions or suggestions: aiguidelines@jhmi.edu 
• Program Director: mbh@jhmi.edu
• Program Administrator: jciekot@jhmi.edu

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Privacy

This website is designed to provide public access to the clinical practice guidelines published by the JHU Clinical Guidelines Program on behalf of and under the direction of the New York State Department of Health AIDS Institute Clinical Guidelines Program.

The JHU Clinical Guidelines Program recognizes the importance of protecting the privacy of visitors to the HIV Clinical Guidelines Program website and subscribers to the site mailing list and the monthly Topic, Trends, and Updates e-mail update.

Stored information: Most information transmitted over the Internet is not secure; thus, confidentiality cannot be guaranteed. However, of the information transmitted via your visit to the Clinical Guidelines Program website, we store the following: the IP address from which you access the Internet, the date and time, the Internet address of the Website from which you linked directly to our site, the name of the file or the words you searched, and the browser used to access our site. This information is used to measure the number of visitors to the various sections of our site and identify system performance or problem areas. We also use this information to help us improve the features of the site and to make the site more useful.

Personally provided information: If you choose to provide us with personal information by sending an email, or by subscribing to one or both of our mailing lists and submitting that information it through our Website, we will use that information to respond to your message, to send you email that you have asked to receive and to help us provide you with information or material that you may request. We do not give, share, sell, or transfer any of your personal information to a third party unless required by law.

If you submit a question that would be best answered by a staff member of the NYSDOH AIDS Institute, we may forward your question to that staff member. When we do, we may or may not include your email address so the staff member may respond to you directly. Submitting a question through this website constitutes your tacit agreement with the actions the JHU website managers may take to secure the best answer possible in a timely manner.

Links to other sites: For the convenience of those who access and use the content published on this site (i.e., the site users), many pages contain links to Web pages and Websites that are not managed by the JHU Clinical Guidelines program. Neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute Clinical Guidelines Program control or take responsibility for the content of those Websites. Links from this Website to Websites not managed by any of the entities named above do not imply endorsement or credibility of the service, information, or product offered through the linked sites. Links are provided to make it easy for users to access supplementary content. 

Some pages on this site provide links to other Websites that provide health information. Once a user links to another site, she or he is subject to the privacy policy of that other site.

Disclaimer: The information provided in this privacy statement should not be construed as giving business, legal, or other advice, or warranting as fail-proof, the security of information provided through this website.

Terms of Use

While every possible effort is made to post accurate and reliable information on this website, neither the JHU Clinical Guidelines Program, neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute HIV Clinical Guidelines Program assumes responsibility for the use or application of information posted on any page of this website or guarantees or warrants that the information posted on any page of this site is complete and without any error or inaccuracy. The website, its editors, advisers, staff, authors, and sponsoring institutions assume no responsibility for any error, omissions, or other discrepancies between the electronic documents published on this site and source materials.

Physicians and other healthcare professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience.

Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition or treatment and are encouraged to call or see their physician or other health care provider promptly with any health-related questions or concerns they may have.

This website links to websites maintained by other entities. Reasonable precautions are taken to link only to websites that publish appropriate and accurate material and are maintained by reputable organizations. However, those web pages are not under the direction or control of this website, and this website can therefore not be held responsible for the information or opinions expressed in those linked sites.

Copyright and Permissions

The use, reproduction, and distribution of original documents and related graphics from this web site are encouraged provided that full credit of source accompanies all uses, in all forms. Please note that if we have adapted or reproduced copyrighted material from another source, with permission, we cannot extend permission to reproduce. Links to pages on this site are also encouraged and may be created without seeking permission.

Any use of materials from this site should be accompanied by the following citation of source: 

This material was accessed on [dd/mo/year] on the HIV Clinical Resource website (www.hivguidelines.org). The HIV Clinical Guidelines Program is a collaborative effort of the New York State Department of Health AIDS Institute and the Johns Hopkins University Division of Infectious Diseases. Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2023. 

Requests to adapt material, i.e., to change or alter in any way material from this site for inclusion in another publication, should be sent to aiguidelines@jhmi.edu. Please include detailed information about the intended use and desired adaptations.

The names of the New York State Department of Health, the Johns Hopkins University Division of Infectious Diseases, Clinical Guidelines Program, or its staff may not be used in publicity or advertising without express written permission. Exceptions to this include listings on web indexes, search engines, and related systems.

Contact Us

Mailing address:

JHU Clinical Guidelines Program
1550 Orleans Street, CRB II, Office 1M11
Baltimore, MD, 21287-0014

E-mail addresses:

• General comments or questions: aiguidelines@jhmi.edu 
• Content-specific comments, questions or suggestions: aiguidelines@jhmi.edu 
• Program Director: mbh@jhmi.edu
• Program Administrator: jciekot@jhmi.edu

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Please note: The email addresses above are for submission of questions or feedback about the website or the guidelines. The New York State Department of Health AIDS Institute Clinical Guidelines Program is not a clinical consultative service. Individuals should consult with a care provider regarding specific patient needs and circumstances. Questions about individual and specific health issues will not be answered.

Subscribe to Receive Topics, Trends & Updates Monthly

Stay up-to-date with the monthly Topics, Trends & Updates e-mail

The monthly Topics, Trends & Updates email keeps subscribers up-to-date regarding new and updated clinical guidelines, hot topics, upcoming events, developments in the field, and What We’re Reading.

Privacy: We do not sell, rent, or share our email lists with anyone.